![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
Center for Gastroenterological Research, Catholic University of Leuven, Leuven, Belgium (B.D.S., I.D., J.T., T.L.P.); Johnson & Johnson Pharmaceutical Research and Development, A Division of Janssen Pharmaceutica, Beerse, Belgium (D.M., B.M., K.C., B.C.); and Laboratory for Physiology of Domestic Animals, Department of Animal Production, Catholic University of Leuven, Leuven, Belgium (Q.S., J.B.)
Received June 29, 2005; accepted September 30, 2005.
| Abstract |
|---|
|
|
|---|
Besides GH release, ghrelin is thought to play an important role in the regulation of the energy balance. Indeed, both central and peripheral administration of ghrelin stimulates food intake in a dose-dependent manner in rodents (Nakazato et al., 2001
) and humans (Wren et al., 2001
). The orexigenic effect of ghrelin is mediated via the vagal nerve (Date et al., 2002
) and via hypothalamic centers. It results in body weight gain partly due to the increased food intake but also due to decreased fat utilization, resulting in adiposity (Tschop et al., 2000
).
Surprisingly, the largest amount of ghrelin is found in the stomach, and ghrelin plasma levels are strongly reduced by gastrectomy (Ariyasu et al., 2001
). This suggests a role for ghrelin in the regulation of the gastrointestinal system. Ghrelin is as yet the only peptide with significant sequence identity with motilin. Moreover, the receptors of motilin and ghrelin also share a marked sequence homology, and together they constitute a new subfamily within class A of rhodopsin like G protein-coupled receptors. It is generally accepted that motilin is involved in the regulation of the migrating motor complex and that it can accelerate gastric emptying. Similar effects have now been observed with ghrelin and with synthetic growth hormone secretagogues. Indeed, ghrelin accelerates gastric emptying in rodents and humans and is able to overcome postoperative ileus (Trudel et al., 2002
; De Winter et al., 2004
; Tack et al., 2005b
) in a dose-dependent manner. Also, peptide (e.g., H-His-D-Trp-Ala-Trp-D-Phe-Lys-NH2) and nonpeptide [e.g., capromorelin (2-amino-N-[(1R)-1-[[(3aR)-3a-benzyl-2,3,3a,4,6,7-hexahydro-2-methyl-3-oxo-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-2-benzylo-xy)ethyl]-2-methylpropionamide)] growth hormone secretagogues show gastroprokinetic properties in mice and rats (Depoortere et al., 2005
; Kitazawa et al., 2005
). Recent studies also show that ghrelin induces premature interdigestive motility patterns in rats and humans (Fujino et al., 2003
; Tack et al., 2005a
). In humans, the effect is not mediated through the release of motilin (Tack et al., 2005a
).
To further define the endogenous role of ghrelin, we generated mice in which the ghrelin gene was deleted. The role of ghrelin in the regulation of the energy balance was investigated by comparing food intake, respiratory quotient, and heat production between young and old wild-type (ghrelin+/+) and ghrelin knockout (ghrelin-/-) mice. Effects on gastrointestinal motility were analyzed by comparing gastric emptying parameters, as deduced from the [14C]octanoic breath test, between the two genotypes. In addition the effect of exogenous administration of ghrelin on food intake and gastric emptying was determined in ghrelin+/+ and ghrelin-/- mice to elucidate whether the ghrelin/GHS-R pathway was still functional.
| Materials and Methods |
|---|
|
|
|---|
Generation of ghrelin-/- Mice. Ghrelin knockout (ghrelin-/-) mice were developed by Lexicon Genetics Incorporated (The Woodlands, TX). A genomic clone spanning 12.4 kb of the ghrelin gene including exons 2 to exon 4, isolated by screening of the 129SvEvBrd-derived lambda pKOS genomic library (Wattler et al., 1999
), was used to generate the targeting vector. A LacZ/Neo reporter/selection cassette was inserted as a SfiI fragment to replace a 285-bp ghrelin genomic fragment that includes the coding region of exon 2 up to exon 3 after yeast-mediated homologous recombination. The NotI-linearized vector was electroporated into 129 Sv/Evbrd(LEX1) embryonic stem cells, and G418-fialuridine-resistant embryonic stem cell clones were isolated and analyzed for homologous recombination by Southern blot analysis. Targeted embryonic stem cell clones were injected into C57BL/6(albino) blastocysts, and the resulting chimeras were mated to C57BL/6(albino) females to generate heterozygous animals. These were subsequently crossed to generate all three genotypes used in the resorted studies. PCR was used to screen genotypes by using DNA isolated from mouse tail biopsy samples. Primers 5'-CCTGGCAGACAGAGCACCTG-3' and 5'-CAGGTCAGTCAAGTCTGTCTC-3' amplified an 842-bp band from the wild-type allele, whereas primers 5'-CCTGGCAGACAGAGCACCTG-3' and 5'-GCAGCGCATCGCCTTCTATC-3' amplified a 630-bp band from the knockout allele. Quantitative RT-PCR analysis was used to show absence of the ghrelin transcript. Total RNA was isolated from different tissues using TRIzol (Invitrogen, Carlsbad, CA), and first strand cDNA synthesis was performed on 0.5 µg of total RNA using random hexamer primers and SuperScript II RT (Invitrogen). Quantitative PCR was performed on an ABI Prism 7700 cycler (Applied Biosystems, Foster City, CA) using a TaqMan PCR kit. Serial dilutions of cDNA were used to generate standard curves of threshold cycles versus the logarithms of concentration for
-actin and ghrelin. A linear regression line calculated from the standard curves allowed the determination of transcript levels in RNA samples from mice. The ghrelin primer-probe pair (primer 5'-GGCAGGCTCCAGCTTCCT-3' primer 5'-TGGCTTCTTGGATTCCTTTCTC-3', probe 5'-AGCCCAGAGCACCAGAAAGCCCA-3' [5']5-carboxyfluorescein [3']5-carboxytetramethylrhodamine) relative to actin (primer 5'-CATCTTGGCCTCACTGTCCAC-3', primer 5'-GGGCCGGACTCATCGTACT-3', probe 5'-TGCTTGCTGATCCACATCTGCTGGA-3' [5']5-carboxyfluorescein [3']5-carboxytetramethylrhodamine) was used to assess expression levels.
Immunohistochemistry. Mice were deeply anesthetized (60-85 mg/kg pentobarbital, intraperitoneally) and perfused transcardially for 5 min with 0.9% NaCl (37°C) and then for 20 min with 4% paraformaldehyde (4°C). Stomach sections (14 µm) were cut with a cryostat and incubated for 2 h in 0.1 M phosphate-buffered saline containing 4% goat serum, 0.5% Triton X-100, and 0.3% NaN3 at 4°C. After incubation overnight with the rabbit anti-ghrelin antibody (dilution 1:500; kindly provided by Dr. Tomasetto, INSERM, Strasbourg, France), sections were washed and incubated with fluorescein isothiocyanate-conjugated goat anti-rabbit IgG (dilution 1:50) (Jackson ImmunoResearch Laboratories Inc., West Grove, PA) for 2 h at 4°C. After three washes of 5 min in 0.1 M phosphate-buffered saline, the sections were mounted with Citifluor (Citifluor Ltd., London, UK).
Body Weight. Body weight was measured every week or every 2 weeks (except between weeks 32 and 41) between 10:00 AM and 12:00 PM from week 12 until week 75 after birth. Initially, these data were fitted according to three different growth models: the Bertalanffy model (Di Masso et al., 1990
), the Gompretz model (Kidwell et al., 1969
), and a logistic model (Pahl, 1969
). The best fit was obtained after fitting to the Gompretz model; thus, this model was further used. The equation of this model is as follows,
![]() | (1) |
Food Intake. Food intake in young mice during the light period (13 h) and the dark period (11 h) was measured daily for 1 week.
Food intake analysis during 6 h in ad libitum fed mice was started at 10:00 AM. Each mouse was put in an individual cage, where it received a preweighed amount of food. Food intake was measured by subtracting the uneaten food at 30 min and 1, 2, 3, 4, 5, and 6 h. Cumulative food intake was calculated and plotted as a function of time.
To analyze the orexigenic effects of ghrelin in ad libitum fed mice, 200 µl of 0.9% saline or 1, 6, 15, 30, 50, or 75 nmol/kg ghrelin (Global Peptide Services, Ft. Collins, CO) or 15 or 30 nmol/kg des-octanoyl ghrelin (kindly provided by Dr. P. Robberecht, Université Libre de Bruxelles, Brussels, Belgium) was injected intraperitoneally immediately before the mice received the food. Mice were sensitized to intraperitoneal injections before the start of the experiment. These results are presented as the difference in cumulative food intake after 6 h between ghrelin or des-octanoyl ghrelin and saline-injected mice as a function of the administered dose.
Indirect Calorimetry. Respiratory quotient (RQ) and heat production (HP) were measured for 24 h in ad libitum fed mice by using an open circuit indirect calorimetric unit. The respiration unit consists of six respiratory cells, placed two by two in three separate light- and temperature-controlled climatic chambers, a gas analyzer unit, and a data acquisition system (Buyse et al., 1998
). The respiratory cells are made of stainless steel, with little insulation, and the temperature inside is measured by a platinum resistance temperature detector (Pt-100; Farnell In One, Grace-Hollogne, Belgium) (accuracy of 0.2°C). The paramagnetic O2 analyzer (ADC 02-823A) and the infrared CO2 analyzer (ADC D/8U/54/A) were calibrated before each measurement by using gas standards.
Mice were placed in the respiratory cells 24 h before the start of the experiment. After the adaptation period, gas exchanges (CO2 and O2) were measured continuously during 24 h for four consecutive days. Mice had free access to food and water, and 24-h food intake was followed. During this experiment, no exogenous ghrelin was administered.
O2 and CO2 concentrations from air samples coming out of each cell were measured for 60 s every 15 min during 24 h. The CO2 production and the O2 consumption were calculated from the differences between the gas concentrations of the outside fresh air and the cell air. RQ is the ratio of CO2 produced to the volume of O2 consumed. Heat production was calculated according to the formula of Romijn and Lokhorst (1961
):
![]() | (2) |
Gastric Emptying Studies: Breath Test. Gastric emptying in mice was measured with the [14C]octanoic acid breath test as described by Kitazawa et al. (2005
). Briefly, after an overnight fast (19 h, free access to water), mice were injected intraperitoneally, if applicable, with 0.9% saline or 1, 30, 75, and 125 nmol/kg ghrelin.
A baseline breath sample (5 min) was taken 23 min after the injection, and 30 min later, the [14C]octanoic-labeled test meal was given to the mice. Before the start of the experiment, fasted mice were trained twice weekly at a fixed time schedule for 2 weeks (2- or 3-day interval) to eat spontaneously the test meal (without radioactive marker) within 60 s. Sampling of exhaled breath was performed every 5 min during the first 30 min and then every 15 min for the next 3.5 h. From the 14CO2 excretion curve, two parameters, thalf (time at which 50% of the total amount of 14CO2 was excreted) and tlag (initial delay in gastric emptying due to the time required for the stomach to grind the meal into fine particles) were calculated as described previously (Kitazawa et al., 2005
).
The time interval between two breath tests was set at 3 to 4 days. To test the effect of exogenous ghrelin on gastric emptying, each group of mice first underwent a control breath test (saline injection) followed by two consecutive breath tests with increasing doses of ghrelin and again a control breath test. The effect of ghrelin was compared with the mean of the control breath tests given before and after the injection of ghrelin.
Statistical Analysis. Data are presented as mean ± S.E.M. Growth curve parameters, 24-h food intake, and gastric emptying parameters were compared with an unpaired t test. Cumulative food intake, respiratory quotient, and heat production were analyzed by two-way analysis of variance, with one repeated measures factor (time). The effect of exogenous ghrelin on food intake and on gastric emptying was analyzed by two-way analysis of variance, with two repeated measure factors. In case of significant factor effects, tests with contrasts were performed to locate pairs of factor levels with significant differences in the examined variables. Data were analyzed with Statistica 6.0 (StatSoft, Tulsa, OK), and significance was accepted at the P < 0.05 level. Dose-response curves to exogenous ghrelin were fitted according to a Gaussian distribution (Prism 4.0; GraphPad Software Inc., San Diego, CA).
| Results |
|---|
|
|
|---|
|
|
|
|
|
|
Effect of Exogenous Administration of Ghrelin on Food Intake. To determine whether the ghrelin/GHS-R pathway was still functional in the absence of ghrelin, food intake after intraperitoneal administration of different doses (1-75 nmol/kg) of ghrelin was compared between young ghrelin-/- and wild-type mice. Results show the difference in cumulative food intake after 6 h between ghrelin- and saline-injected mice as a function of the administered dose. The dose-response relationship to ghrelin was bell-shaped in both genotypes (Fig. 7). The curve of the ghrelin-/- mice was shifted to the left and had a more narrow activity range than that of the ghrelin+/+ mice. The optimal dose to stimulate food intake in ghrelin-/- mice (10.8 ± 4.9 nmol/kg) was 3.3-fold lower than in ghrelin+/+ mice (35.9 ± 17.5 nmol/kg).
|
To investigate whether the octanoyl modification of ghrelin on Ser3 is essential for the orexigenic properties of ghrelin, both genotypes were injected with a dose of des-octanoyl ghrelin that was close to the maximal effective dose of ghrelin. Des-octanoyl ghrelin did not stimulate food intake [cumulative food intake after 6 h (
NaCl)] in ghrelin+/+ mice (30 nmol/kg: ghrelin, 0.53 ± 0.09 g versus des-octanoyl ghrelin, 0.00 ± 0.11 g) or in ghrelin-/- mice (15 nmol/kg: ghrelin, 0.35 ± 0.15 g versus des-octanoyl ghrelin, -0.27 ± 0.14 g).
RQ and HP
To obtain more information on the proportion of fat and carbohydrate oxidation, CO2 production and O2 consumption were determined. From their ratio, the RQ was obtained, whereas HP was calculated as described under Materials and Methods.
No differences in RQ value were found between both genotypes during the light period (ghrelin+/+, 1.02 ± 008; ghrelin-/-, 1.00 ± 0.007; two groups of five mice for each genotype, age 23 weeks), but during the dark period, the RQ value of the ghrelin-/- mice (1.06 ± 0.008) was significantly (P < 0.001) lower than that of the ghrelin+/+ mice (1.10 ± 0.009) (Fig. 8A). This effect disappeared with aging because in old mice the RQ value did not differ between both genotypes either during the light (ghrelin+/+, 0.98 ± 0.007 versus ghrelin-/-, 1.02 ± 0.008; age 54 weeks) or the dark phase (ghrelin+/+, 1.02 ± 0.004 versus ghrelin-/-, 1.06 ± 0.008; two groups of five mice for each genotype; Fig. 8C).
|
Gastric Emptying Studies
Gastric Emptying of Young and Old Mice. To investigate the gastroprokinetic effects of ghrelin, gastric emptying in both young (age 15 weeks) and old (age 60 weeks) ghrelin-/- mice was analyzed. Figure 9 shows the average 14CO2 excretion curves obtained from both genotypes. No significant differences in gastric emptying parameters between mice of both genotypes were observed. The thalf value was 90.72 ± 5.71 min for the ghrelin+/+ mice and 91.90 ± 2.03 min for the ghrelin-/- mice, whereas the tlag value was 42.17 ± 1.93 and 39.71 ± 3.02 min, respectively (n = 6 for each genotype). In addition, in old mice, no difference in gastric emptying parameters was observed between the two genotypes; however, thalf (ghrelin+/+ mice, 66.60 ± 5.76 min; ghrelin-/- mice, 57.80 ± 3.00 min; n = 8-9 for each genotype) and tlag (ghrelin+/+, 35.20 ± 3.51 min; ghrelin-/-, 31.02 ± 1.62 min) were significantly shorter than in the young mice, indicating that gastric emptying was accelerated in older animals.
|
|
A similar bell-shaped dose-response relationship to exogenous ghrelin was observed in age-matched ghrelin-/- mice (n = 8). The maximal effect was estimated to occur for thalf at 48.72 ± 25.27 nmol/kg and for tlag at 54.71 ± 30.17 nmol/kg (Fig. 10).
| Discussion |
|---|
|
|
|---|
However, our study showed that when the normal light/dark cycle was interrupted by turning the lights artificially off, food intake in old ghrelin+/+ but not in ghrelin-/- mice was stimulated. This difference was absent in the young ghrelin-/- mice. Enhanced ghrelin signaling or a sudden increase in plasma ghrelin levels could trigger this event. Sanchez et al. (2004
) showed a sharp rise in blood ghrelin levels just before the onset of the dark period, which is the active feeding period of rodents. Together with our findings, this suggests that ghrelin may function as an endogenous meal-initiating signal that is triggered by the dark/light cue. The fact that this effect does not occur in young animals suggests the involvement of compensatory mechanisms that are lost during aging. Also in humans, it was shown (Cummings et al., 2001
) that ghrelin plays a role as a meal initiator because plasma ghrelin levels of healthy volunteers increase before the meal. However, this seemed to be independent of time- or food-related cues (Cummings et al., 2004
).
Recent studies in GHS-R-null mice showed that the effect of ghrelin on GH secretion and on food intake is mediated by the GHS-R (Sun et al., 2004
). To elucidate whether the ghrelin/GHS-R pathway was still functional in the absence of ghrelin, the effect of exogenous administration of ghrelin on food intake was evaluated. In both genotypes, ghrelin stimulated food intake with a bell-shaped dose-response relationship. There are many reasons for bell-shaped dose-response curves. Desensitization is one of the possibilities, especially because the ghrelin receptor is susceptible to rapid desensitization (Orkin et al., 2003
; Camina et al., 2004
). Another possibility is that, at higher doses of ghrelin, anorectic pathways are activated as a kind of feedback mechanism. In ghrelin-/- mice, the dose-response curve was shifted toward lower concentrations and had a more narrow activity range. This suggests an up-regulation and/or a change in sensitivity of the GHS-R involved in the regulation of food intake, but it may also suggest that the receptor is more vulnerable to desensitization.
To gain more insight in the metabolic characteristics of the ghrelin-/- mice, RQ and HP were determined by using indirect calorimetry. Because no differences in food consumption were observed, gross energy intake was similar for both genotypes. There are no indications (e.g., absence of difference in gastric emptying rate) that the metabolizability of gross energy might be different between these genotypes; hence, a similar metabolizable energy intake can be inferred. This energy can be retained in the body or alternatively must be dissipated as heat. Thus, the total amount of heat produced plus the amount of energy retained must equal metabolizable energy intake. Because young ghrelin-/- mice have a higher heat production compared with the ghrelin+/+ mice, it follows that ghrelin-/- mice must retain a lower amount of the metabolized energy. Given their similar body weights, the lower energy retention suggests that the ghrelin-/- mice have a leaner body composition (higher lean-to-fat ratio). Another group (Wortley et al., 2004
) indeed observed a tendency toward a leaner body composition in ghrelin-/- mice compared with normal mice, although only when fed on a high-fat diet. Sun et al. (2003
) did not find any changes in body composition between ghrelin-/- and ghrelin+/+ mice fed on a standard diet, although it should be pointed out that this study was performed in 8-week-old mice. Our study clearly indicates that age-related changes may play an important role since changes in RQ and heat production were observed in 23- but not in 54-week-old ghrelin+/+ and ghrelin-/- mice, suggesting that the role of ghrelin dampens with age. Supportive for our hypothesis of a leaner body composition is that in the fed state young ghrelin-/- mice have a lower RQ than the corresponding wild-type littermates. Indeed, an RQ value above unity is indicative for de novo fatty acid synthesis (Ferrannini, 1988
). Because the RQ values of the ghrelin-/- mice did not exceed unity to the same extent as the ghrelin+/+ mice, a relatively lower de novo lipogenesis can be inferred in the ghrelin-/- mice. This supports previous reports on the adipogenic effects of exogenous ghrelin in mice (Tschop et al., 2000
).
The effect of genetic deletion of ghrelin on gastric emptying was evaluated by using the [14C]octanoic breath test, as described and validated by Kitazawa et al. (2005
). No changes in gastric emptying parameters thalf and tlag between young or old ghrelin+/+ and ghrelin-/- mice were found. This may suggest that endogenous ghrelin does not play a critical role in gastric emptying or that the effect of ghrelin is compensated by other mechanisms. Exogenous ghrelin accelerated gastric emptying in ghrelin-/- mice in a bell-shaped, dose-dependent manner, but in contrast to the effect on food intake no shift in the dose-response curve of the ghrelin-/- mice was observed. This suggests that the effects on food intake and gastric emptying are mediated via different pathways. Previous studies have shown that the starvation signal and the effect on motility by ghrelin are relayed to the brain via vagal afferents (Masuda et al., 2000
; Date et al., 2002
; Fujino et al., 2003
), whereas the effect on motility may also depend upon activation of peripheral receptors (Depoortere et al., 2003
, 2005
; Kitazawa et al., 2005
; Xu et al., 2005
). Selective up- and/or down-regulation of central and peripheral receptors may determine the final effect of exogenous ghrelin on food intake and gastric emptying.
In conclusion, ghrelin is not a critical endogenous factor or has a redundant role in the regulation of food intake and gastric emptying in young and old mice. Instead, the primary orexigenic effect of ghrelin in old mice may be to function as an endogenous meal-initiating signal, and this effect is triggered by the light/dark cue. Metabolism studies revealed that in young animals, ghrelin is likely to be involved in the preference of metabolic fuel oxidation and in the partitioning of metabolizable energy between storage and dissipation as heat, leading to an altered body composition.
| Footnotes |
|---|
Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.
ABBREVIATIONS: GHS-R, growth hormone secretagogue receptor; GH, growth hormone; kb, kilobase(s); bp, base pairs(s); RT, reverse transcription; PCR, polymerase chain reaction; RQ, respiratory quotient; HP, heat production; NPY, neuropeptide Y; AgRP, agouti-related peptide.
Address correspondence to: Dr. Inge Depoortere, Centre for Gastroenterological Research, Gasthuisberg, O&N, bus 701, 3000 Leuven, Belgium. E-mail: inge.depoortere{at}med.kuleuven.be
| References |
|---|
|
|
|---|
Ariyasu H, Takaya K, Tagami T, Ogawa Y, Hosoda K, Akamizu T, Suda M, Koh T, Natsui K, Toyooka S, et al. (2001) Stomach is a major source of circulating ghrelin and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 86: 4753-4758.
Buyse J, Michels H, Vloeberghs J, Saevels P, Aerts JM, Ducro B, Berckmans D, and Decuypere E (1998) Energy and protein metabolism between 3 and 6 weeks of age of male broiler chickens selected for growth rate or for improved food efficiency. Br Poult Sci 39: 264-272.[Medline]
Camina JP, Carreira MC, El Messari S, Llorens-Cortes C, Smith RG, and Casanueva FF (2004) Desensitization and endocytosis mechanisms of ghrelin-activated growth hormone secretagogue receptor 1a. Endocrinology 145: 930-940.
Chen HY, Trumbauer ME, Chen AS, Weingarth DT, Adams JR, Frazier EG, Shen Z, Marsh DJ, Feighner SD, Guan XM, et al. (2004) Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology 145: 2607-2612.
Cowley MA, Smith RG, Diano S, Tschop M, Pronchuk N, Grove KL, Strasburger CJ, Bidlingmaier M, Esterman M, Heiman ML, et al. (2003) The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37: 649-661.[CrossRef][Medline]
Cummings DE, Frayo RS, Marmonier C, Aubert R, and Chapelot D (2004) Plasma ghrelin levels and hunger scores in humans initiating meals voluntarily without time- and food-related cues. Am J Physiol 287: E297-E304.
Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, and Weigle DS (2001) A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50: 1714-1719.
Date Y, Murakami N, Toshinai K, Matsukura S, Niijima A, Matsuo H, Kangawa K, and Nakazato M (2002) The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 123: 1120-1128.[CrossRef]
Depoortere I, De Winter B, Thijs T, De Man J, Pelckmans P, and Peeters T (2005) Comparison of the prokinetic effects of ghrelin, GHRP-6 and motilin in rats in vivo and in vitro. Eur J Pharmacol 515: 160-168.[CrossRef][Medline]
Depoortere I, Thijs T, Thielemans L, Robberecht P, and Peeters TL (2003) Interaction of the growth hormone-releasing peptides ghrelin and growth hormone-releasing peptide-6 with the motilin receptor in the rabbit gastric antrum. J Pharmacol Exp Ther 305: 660-667.
De Winter BY, De Man JG, Seerden TC, Depoortere I, Herman AG, Peeters TL, and Pelckmans PA (2004) Effect of ghrelin and growth hormone-releasing peptide 6 on septic ileus in mice. Neurogastroenterol Motil 16: 439-446.[CrossRef][Medline]
Dickson SL and Luckman SM (1997) Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6. Endocrinology 138: 771-777.
Di Masso RJ, Rucci AN, and Font MT (1990) Growth analysis in two lines of rats and their reciprocal F1 crosses under two nutritional environments: heterosis for body weight and maturing rate. Growth Dev Aging 54: 117-123.[Medline]
Erickson JC, Clegg KE, and Palmiter RD (1996) Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature (Lond) 381: 415-421.[CrossRef][Medline]
Ferrannini E (1988) The theoretical bases of indirect calorimetry: a review. Metabolism 37: 287-301.[CrossRef][Medline]
Fujino K, Inui A, Asakawa A, Kihara N, Fujimura M, and Fujimiya M (2003) Ghrelin induces fasted motor activity of the gastrointestinal tract in conscious fed rats. J Physiol (Lond) 550: 227-240.
Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, et al. (1996) A receptor in pituitary and hypothalamus that functions in growth hormone release. Science (Wash DC) 273: 974-977.[Abstract]
Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, and Wakabayashi I (2000) Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression. Endocrinology 141: 4797-4800.
Kidwell JF, Howard A, and Laird AK (1969) The inheritance of growth and form in the mouse: II. The Gompretz growth equation. Growth 33: 339-352.[Medline]
Kitazawa T, De Smet B, Depoortere I, Moreaux B, Verbeke K, Tack J, Coulie B, and Peeters TL (2005) Gastric motor effects of peptide and non-peptide ghrelin agonists in mice in vivo and in vitro. Gut 54: 1078-1084.
Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, and Kangawa K (1999) Ghrelin is a growth hormone-releasing acylated peptide from stomach. Nature (Lond) 402: 656-660.[CrossRef][Medline]
Masuda Y, Tanaka T, Inomata N, Ohnuma N, Tanaka S, Itoh Z, Hosoda H, Kojima M, and Kangawa K (2000) Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun 276: 905-908.[CrossRef][Medline]
Murray CD, Kamm MA, Bloom SR, and Emmanuel AV (2003) Ghrelin for the gastroenterologist: history and potential. Gastroenterology 125: 1492-1502.[CrossRef]
Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, and Matsukura SA (2001) A role for ghrelin in the central regulation of feeding. Nature (Lond) 409: 194-198.[CrossRef][Medline]
Orkin RD, New DI, Norman D, Chew SL, Clark AJ, Grossman AB, and Korbonits M (2003) Rapid desensitisation of the GH secretagogue (ghrelin) receptor to hexarelin in vitro. J Endocrinol Investig 26: 743-747.[Medline]
Pahl PJ (1969) Growth curves for body weight of the laboratory rat. Aust J Biol Sci 22: 1077-1780.[Medline]
Qian S, Chen H, Weingarth D, Trumbauer ME, Novi DE, Guan X, Yu H, Shen Z, Feng Y, Frazier E, et al. (2002) Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Mol Cell Biol 22: 5027-5035.
Romijn C and Lokhorst W (1961) Some aspects of energy metabolism in birds, in Proceedings of the 2nd Symposium on Energy Metabolism of Farm Animals, European Association for Animal Production, Vol. 10, pp 49-59, Wageningen Academic Publishers, Wageningen, The Netherlands.
Sanchez J, Oliver P, Pico C, and Palou A (2004) Diurnal rhythms of leptin and ghrelin in the systemic circulation and in the gastric mucosa are related to food intake in rats. Pflueg Arch Eur J Physiol 448: 500-506.[Medline]
Seoane LM, Lopez M, Tovar S, Casanueva FF, Senaris R, and Dieguez C (2003) Agouti-related peptide, neuropeptide Y and somatostatin-producing neurons are targets for ghrelin actions in the rat hypothalamus. Endocrinology 144: 544-551.
Shimada M, Tritos NA, Lowell BB, Flier JS, and Maratos-Flier E (1998) Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature (Lond) 396: 670-674.[CrossRef][Medline]
Sun Y, Ahmed S, and Smith RG (2003) Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol 23: 7973-7981.
Sun Y, Wang P, Zheng H, and Smith RG (2004) Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci USA 101: 4679-4684.
Tack J, Depoortere I, Bisschops R, Delporte C, Coulie B, Meulemans A, Janssens J, and Peeters T (2005a) Influence of ghrelin on interdigestive gastrointestinal motility in man. Gut, in press.
Tack J, Depoortere I, Bisschops R, Verbeke K, Janssens J, and Peeters T (2005b) Influence of ghrelin on gastric emptying and meal-related symptoms in iodopathic gastroparesis. Aliment Pharmacol 22: 847-853.
Toshinai K, Date Y, Murakami N, Shimada M, Mondal MS, Shimbara T, Guan JL, Wang QP, Funahashi H, Sakurai T, et al. (2003) Ghrelin-induced food intake is mediated via the orexin pathway. Endocrinology 144: 1506-1512.
Trudel L, Tomasetto C, Rio MC, Bouin M, Plourde V, Eberling P, and Poitras P (2002) Ghrelin/motilin-related peptide is a potent prokinetic to reverse gastric postoperative ileus in rat. Am J Physiol 282: G948-G952.
Tschop M, Smiley DL, and Heiman ML (2000) Ghrelin induces adiposity in rodents. Nature (Lond) 407: 908-913.[CrossRef][Medline]
Xu L, Depoortere I, Tomasetto C, Zandecki M, Tang M, Timmermans JP, and Peeters TL (2005) Evidence for the presence of motilin, ghrelin and the motilin and ghrelin receptor in neurons of the myenteric plexus. Regul Pept 124: 119-125.[CrossRef][Medline]
Wattler S, Kelly M, and Nehls M (1999) Construction of gene targeting vectors from lambda KOS genomic libraries. Biotechniques 26: 1150-1160.[Medline]
Wortley KE, Anderson KD, Garcia K, Murray JD, Malinova L, Liu R, Moncrieffe M, Thabet K, Cox HJ, Yancopoulos GD, et al. (2004) Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proc Natl Acad Sci USA 101: 8227-8232.
Wren AM, Seal LJ, Cohen MA, Dhillo WS, Seal LJ, Cohen MA, Batterham RL, Taheri S, Stanley SA, Ghatei MA, and Bloom SR (2001) Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86: 5992.
This article has been cited by other articles:
![]() |
A. V. Mayorov, N. Amara, J. Y. Chang, J. A. Moss, M. S. Hixon, D. I. Ruiz, M. M. Meijler, E. P. Zorrilla, and K. D. Janda Catalytic antibody degradation of ghrelin increases whole-body metabolic rate and reduces refeeding in fasting mice PNAS, November 11, 2008; 105(45): 17487 - 17492. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ariga, K. Imai, C. Chen, C. Mantyh, T. N. Pappas, and T. Takahashi Does ghrelin explain accelerated gastric emptying in the early stages of diabetes mellitus? Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2008; 294(6): R1807 - R1812. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Pfluger, H. Kirchner, S. Gunnel, B. Schrott, D. Perez-Tilve, S. Fu, S. C. Benoit, T. Horvath, H.-G. Joost, K. E. Wortley, et al. Simultaneous deletion of ghrelin and its receptor increases motor activity and energy expenditure Am J Physiol Gastrointest Liver Physiol, March 1, 2008; 294(3): G610 - G618. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ariga, K. Imai, C. Chen, C. Mantyh, T. N. Pappas, and T. Takahashi Fixed feeding potentiates interdigestive gastric motor activity in rats: importance of eating habits for maintaining interdigestive MMC Am J Physiol Gastrointest Liver Physiol, March 1, 2008; 294(3): G655 - G659. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Wierup, M. Bjorkqvist, B. Westrom, S. Pierzynowski, F. Sundler, and K. Sjolund Ghrelin and Motilin Are Cosecreted from a Prominent Endocrine Cell Population in the Small Intestine J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3573 - 3581. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kristensson, M. Sundqvist, R. Hakanson, and E. Lindstrom High gastrin cell activity and low ghrelin cell activity in high-anxiety Wistar Kyoto rats J. Endocrinol., May 1, 2007; 193(2): 245 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Iantorno, H. Chen, J.-a Kim, M. Tesauro, D. Lauro, C. Cardillo, and M. J. Quon Ghrelin has novel vascular actions that mimic PI 3-kinase-dependent actions of insulin to stimulate production of NO from endothelial cells Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E756 - E764. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Dezaki, H. Sone, M. Koizumi, M. Nakata, M. Kakei, H. Nagai, H. Hosoda, K. Kangawa, and T. Yada Blockade of Pancreatic Islet-Derived Ghrelin Enhances Insulin Secretion to Prevent High-Fat Diet-Induced Glucose Intolerance Diabetes, December 1, 2006; 55(12): 3486 - 3493. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. O. L. Jorgensen A simple twist of science: the convoluted tale of ghrelin continues. J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3279 - 3280. [Full Text] [PDF] |
||||
![]() |
E. P. Zorrilla, S. Iwasaki, J. A. Moss, J. Chang, J. Otsuji, K. Inoue, M. M. Meijler, and K. D. Janda From the Cover: Vaccination against weight gain PNAS, August 29, 2006; 103(35): 13226 - 13231. [Abstract] [Full Text] [PDF] |
||||
![]() |
|